Antithrombin III level in the plasma of patients with AMI was determined dynamically by using the methods of chromogenic substrate and rocket electrophoresis. Meanwhile, plasma specimens of 40 normal subjects were examined with the same method. The results showed that the AT III level in AMI patients was much lower than that in normal controls at the first and third day after infarction. The level was also significantly lower than that at the 7th, 14th and 21st day after the onset of the disease. It revealed that there was a hypercoagulative state in patients within the first three days of infarction. The AT III level in patients who died within ten days was much lower than that in the survivor group, P less than 0.01. The authors concluded that a patient may be in a severe condition when their plasma AT III levels decrease apparently and persistently.